22 January, 2017

Scientists have developed a molecule that reverses antibiotic resistance in multiple strains of bacteria at once by disabling the enzyme known as New Delhi Metallo-beta-lactamase (NDM-1), which makes bacteria resistant to carbapenems (our 'last resort' drugs), in vitro and in vivo in mice.


No comments: